The store will not work correctly when cookies are disabled.
3-(2-Chlorophenyl)-4-((3-(methylthio)phenyl)amino)-1H-pyrrole-2,5-dione
ID: ALA4858023
PubChem CID: 164610380
Max Phase: Preclinical
Molecular Formula: C17H13ClN2O2S
Molecular Weight: 344.82
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1cccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)c1
Standard InChI: InChI=1S/C17H13ClN2O2S/c1-23-11-6-4-5-10(9-11)19-15-14(16(21)20-17(15)22)12-7-2-3-8-13(12)18/h2-9H,1H3,(H2,19,20,21,22)
Standard InChI Key: AUETXHWBTMVYGV-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.3709 -20.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1881 -20.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4425 -19.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7795 -19.0833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1208 -19.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9464 -21.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1271 -21.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7021 -21.7191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0952 -22.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9177 -22.4539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3391 -21.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6677 -21.0038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4810 -21.0035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8861 -21.7099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6986 -21.7099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1058 -21.0048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6944 -20.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8832 -20.3018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2200 -19.3140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3434 -19.3133 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1072 -22.4176 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9244 -22.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7354 -20.3034 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
21 22 1 0
7 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.82 | Molecular Weight (Monoisotopic): 344.0386 | AlogP: 3.54 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.66 | CX Basic pKa: ┄ | CX LogP: 3.18 | CX LogD: 3.18 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.66 | Np Likeness Score: -0.89 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |